For a test topical semisolid product that would satisfy the criteria for Q3 similarity (defined above), demonstrating BE may include all the evidence recommended for a test topical semisolid product that is shown to be Q3 the same as its reference standard, as well as evidence to mitigate the risk of specific failure modes for BE associated with the difference(s) in the components or composition of the test topical product and its reference standard.